Post-earnings recap
Reported
Wed, Nov 5, 2025
EPS actual
$0.68
EPS est.
$0.48
EPS surprise
+42.56%
1-day move
+0.19%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Catalyst Pharmaceuticals reported a strong EPS performance, significantly exceeding expectations. The stock reacted positively, rising 0.19%. However, the lack of revenue details and guidance may leave investors cautious about future growth prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.68 | N/A | +42.56% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting operational strengths. They emphasized a commitment to efficiency without providing specific guidance.
We are pleased with our EPS performance this quarter.
Our focus remains on maintaining strong operational efficiency.